Search company, investor...

NeoMend

neomend.com

Founded Year

1999

Stage

Acquired | Acquired

Total Raised

$66.58M

Valuation

$0000 

About NeoMend

Neomend is engaged in the development and commercialization of surgical sealants that lend themselves to improved patient outcomes. Neomenda's Progel technology is a hydrogel polymer that can be chemically engineered for optimization of key sealant properties in order to effectively meet the needs of targeted surgical procedures. In October 2012, Neomend was acquired by C.R. Bard. The valuation of Neomend was $140 million. Other terms of the deal were not released.

Headquarters Location

60 Technology Drive

Irvine, California, 92618,

United States

949-916-1630

Missing: NeoMend's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: NeoMend's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing NeoMend

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

NeoMend is included in 1 Expert Collection, including Medical Devices.

M

Medical Devices

295 items

Companies that received PMA from the FDA since 2014. Companies tagged as #FDAPMA

NeoMend Patents

NeoMend has filed 12 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

4/5/2011

4/27/2021

Drug delivery devices, Dosage forms, Medical equipment, Digestive system surgery, Medical treatments

Grant

Application Date

4/5/2011

Grant Date

4/27/2021

Title

Related Topics

Drug delivery devices, Dosage forms, Medical equipment, Digestive system surgery, Medical treatments

Status

Grant

Latest NeoMend News

NeoMend Inc. Mergers Acquisitions MA Partnerships Alliances and Investment Report Prices from USD $350

Dec 4, 2016

Home » Topics » Alliances, mergers acquisitions and partnerships » Latest News » NeoMend, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350 Summary MarketLine's Company Mergers Acquisitions MA, Partnerships Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' NeoMend, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investments report includes business description, detailed reports on mergers and acquisitions MA, divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by NeoMend, Inc. since January 2007. Key Findings Provides intelligence on NeoMend, Inc. MA, strategic partnerships and alliances, capital raising and private equity transactions. Detailed reports of various financial transactions undertaken by NeoMend, Inc. and its subsidiaries since 2007. Information about key financial and legal advisors for NeoMend, Inc.'s financial deals transactions. Financial deals tables and charts covering deal value and volumes trend, deal types and geographybased deal activity. ReasonsToBuy Access comprehensive financial deals data along with charts and graph covering MA, private equity, and partnerships and alliances. Form an independent opinion about NeoMend, Inc.'s growth strategies through the organic and inorganic activities undertaken since 2007. Track your competitors' business structure and growth strategies. Related Biotechnology, Pharmaceutical and Healthcare News

NeoMend Frequently Asked Questions (FAQ)

  • When was NeoMend founded?

    NeoMend was founded in 1999.

  • Where is NeoMend's headquarters?

    NeoMend's headquarters is located at 60 Technology Drive, Irvine.

  • What is NeoMend's latest funding round?

    NeoMend's latest funding round is Acquired.

  • How much did NeoMend raise?

    NeoMend raised a total of $66.58M.

  • Who are the investors of NeoMend?

    Investors of NeoMend include C.R. Bard, Sanderling Ventures, Prospect Venture Partners, Novo Holdings, Vivo Capital and 4 more.

  • Who are NeoMend's competitors?

    Competitors of NeoMend include Tepha, Dune Medical Devices, Censis Technologies, Expanding Orthopedics, Paragon Medical and 11 more.

Compare NeoMend to Competitors

C
Clearmedical

ClearMedical is a distributor of remanufactured brand name surgical devices. ClearMedical aims to drive cost savings by selling high-volume, disposable, FDA approved laparoscopic, arthroscopic, and general surgical devices at reduced prices. The company collects used Single-Use-Devices (SUDs) from hospitals, reprocesses them consistent with FDA approvals, and sells them to hospitals and surgery centers wanting to reduce supply acquisition costs. The company's device list includes harmonic scalpels from Ethicon, trocars from Ethicon, US Surgical (AutoSuture), laparoscopic instruments from Ethicon, US Surgical (AutoSuture), clip appliers from ethicon, US Surgical (AutoSuture), linear cutter and staplers from Ethicon, and bone shavers from Linvatec, Smith & Nephew, and Stryker.

N
NeuroLife Noninvasive Solutions

NeuroLife Noninvasive Solutions offers Surgical and medical Instruments and apparatus

TransCorp Logo
TransCorp

TransCorp develops and commercializes minimally invasive surgical instruments and implants for neurosurgical and orthopedic applications.

E
Es Vascular

ES Vascular Ltd. developed first ever surgical stapling devices for endovascular surgery. These devices aim to transform vascular surgery by shortening procedural times, and by simplifying and potentially increasing the safety of the most common vascular interventions. The company is currently developing three product lines for open AAA, endovascular AAA and Femoro-Pop bypass procedures. Its first products are anticipated to enter the market in 2008.nCompany Snapshotn Started in 2000 in Israel by Prof. Shifrin together with group of engineers and leading vascular surgeons from the US and Europe;n Developed a ever vascular stapling technology for stapling synthetic grafts to the aortan Developed endovascular devices for EVAR and SFA procedures

S
Sierra Surgical Technologies

Sierra Surgical Technologies is a developer of minimally invasive surgical systems.

M
MaxiFlex

MaxiFlex, LLC is a spec developer and manufacturer of surgical medical devices specifically in the field of Urology.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.